20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more innovative and pioneering branded medicines.
A landmark deal has been agreed that is set to save the NHS £14 billion over five years in medicines costs, enable patients to access the latest lifesaving treatments more consistently, and boost the UK’s position as a global superpower in advanced healthcare, technology, and clinical research.